216 related articles for article (PubMed ID: 20206544)
1. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
[TBL] [Abstract][Full Text] [Related]
2. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with esophageal cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Ann Thorac Surg; 2011 Oct; 92(4):1239-42; discussion 1243. PubMed ID: 21867990
[TBL] [Abstract][Full Text] [Related]
3. Analysis of multidisciplinary lung cancer practice.
Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
[TBL] [Abstract][Full Text] [Related]
4. Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center.
Chien CR; Lai MS
Am J Med Qual; 2006; 21(6):408-14. PubMed ID: 17077423
[TBL] [Abstract][Full Text] [Related]
5. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
[TBL] [Abstract][Full Text] [Related]
6. The management of non-small-cell lung cancer with oligometastases.
Downey RJ; Ng KK
Chest Surg Clin N Am; 2001 Feb; 11(1):121-32, ix. PubMed ID: 11253594
[TBL] [Abstract][Full Text] [Related]
7. Combined modality therapy for stage III non-small-cell lung cancer.
Anderson CS; Curran WJ
Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
Garland L; Robinson LA; Wagner H
Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
[TBL] [Abstract][Full Text] [Related]
9. [Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma].
Jassem J; Biernat W; Drosik K; Dziadziuszko R; Kordek R; Kozielski J; Kowalski DM; Krzakowski M; Nikliński J; Olszewski W; Orłowski T; Ramlau R; Roszkowski-Śliż K; Rzyman W
Pneumonol Alergol Pol; 2010; 78(6):418-31. PubMed ID: 21077034
[No Abstract] [Full Text] [Related]
10. [Recommendations on the therapy of bronchial carcinoma].
Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
[No Abstract] [Full Text] [Related]
11. Treatment of stage I lung cancer.
Walsh GL; Pisters KM; Stevens C
Chest Surg Clin N Am; 2001 Feb; 11(1):17-38, vii. PubMed ID: 11253597
[TBL] [Abstract][Full Text] [Related]
12. Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
Bordoni R
Oncologist; 2008 Sep; 13(9):945-53. PubMed ID: 18779538
[TBL] [Abstract][Full Text] [Related]
13. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
Patel V; Shrager JB
Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
[TBL] [Abstract][Full Text] [Related]
14. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
15. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
Reck M; Rosell R; Tiemann M
Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
[No Abstract] [Full Text] [Related]
17. Stage IIIB non-small-cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
[TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
19. [To improve the survival rate of patients suffering from locally advanced non-small cell lung cancer with combination of radiotherapy and chemotherapy].
Zhu GY
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):88-90. PubMed ID: 17445466
[No Abstract] [Full Text] [Related]
20. Stage II (T3) lung cancer.
Allen MS; Jett JR; Kozelsky TF
Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
